BridgeMD
New treatment option for Class I Malocclusion
Official title Nano Coated Orthodontic Miniscrews for en Mass Retraction of the Upper Arch
ClinicalTrials.gov ID: NCT07521267
What this study is testing
- What it's testing
- study will be directed to evaluate silver-hydroxyapatite nano-coated versus uncoated orthodontic miniscrews for en masse retraction of the upper anterior segment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 20
You may be able to join if
- Class I orthodontic cases with bimaxillary protrusion of the anterior segment of the upper jaw that need at least extraction for orthodontic...
- Age 14-20 years.
- Good oral hygiene with healthy periodontium.
- Need for an absolute skeletal anchorage.
- Systemically healthy patients.
You likely can't join if
- Patient with craniofacial anomalies (e.g, cleft lip and palate)
- Presence of systemic diseases or syndromes affecting bone metabolism (e.g, osteoporosis, rickets)
- Poor oral hygiene or uncooperative patients.
- Extensive dental caries or untreated periodontal disease.
- History of trauma or surgery affecting the maxilla or mandible.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 20 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.